303225-22-1 Usage
General Description
4-(Chloromethyl)-3-(2,6-dichlorophenyl)-5-Methylisoxazole is a complex chemical compound encompassing several functional groups: chloromethyl, dichlorophenyl and methyl isoxazole. It belongs to the group of isoxazoles, which is a class of volatile liquid compounds that contain an isoxazole ring, a five membered ring with three carbon atoms, one nitrogen atom, and one oxygen atom. The presence of the chloromethyl and dichlorophenyl groups suggest that this compound may have applications in the field of organic synthesis or as a potential intermediate in the formation of other complex compounds. The complete properties of this specific chemical, including its physical and chemical properties, reactivity, and potential uses, are not widely documented and may require more comprehensive study and characterization.
Check Digit Verification of cas no
The CAS Registry Mumber 303225-22-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,3,2,2 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 303225-22:
(8*3)+(7*0)+(6*3)+(5*2)+(4*2)+(3*5)+(2*2)+(1*2)=81
81 % 10 = 1
So 303225-22-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H8Cl3NO/c1-6-7(5-12)11(15-16-6)10-8(13)3-2-4-9(10)14/h2-4H,5H2,1H3
303225-22-1Relevant articles and documents
3,4,5-Trisubstituted isoxazoles as novel PPARδ agonists: Part 1
Epple, Robert,Russo, Ross,Azimioara, Mihai,Cow, Christopher,Xie, Yongping,Wang, Xing,Wityak, John,Karanewsky, Don,Gerken, Andrea,Iskandar, Maya,Saez, Enrique,Martin Seidel,Tian, Shin-Shay
, p. 4376 - 4380 (2007/10/03)
We report the identification of a novel series of trisubstituted isoxazoles as PPAR activators from a high-throughput screen. A series of structural optimizations led to improved efficacy and excellent functional receptor selectivity for PPARδ. The isoxazoles represent a series of agonists which display a scaffold that lies outside the typical PPAR agonist motif.
